MiMedx Group, Inc. Financing Interest Expense
MiMedx Group, Inc. (MDXG) reported Financing Interest Expense of $439.06 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Expense Statement › Interest Expense
us-gaap:FinancingInterestExpense · last filed 2012-11-13
- MiMedx Group, Inc. financing interest expense for the quarter ending 2012-09-30 was $439.06K, a 444.14% increase year-over-year.
- MiMedx Group, Inc. financing interest expense for the quarter ending 2012-06-30 was $472.75K, a 680.13% increase year-over-year.
- MiMedx Group, Inc. financing interest expense for the quarter ending 2012-03-31 was $218.70K.
- MiMedx Group, Inc. financing interest expense for the quarter ending 2011-12-31 was -$214.21K.
- MiMedx Group, Inc. financing interest expense for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- MiMedx Group, Inc. financing interest expense for fiscal 2010 was $287.45K.
| Period end | Financing Interest Expense 3 month | Financing Interest Expense 6 month | Financing Interest Expense 9 month | Financing Interest Expense 12 month |
|---|---|---|---|---|
| 2012-09-30 | $439.06K 10-Q · filed 2012-11-13 | $911.81K derived: sum of 2 quarters · filed 2012-11-13 | $1.22M 10-Q · filed 2012-11-13 | $916.31K derived: sum of 4 quarters · filed 2012-11-13 |
| 2012-06-30 | $472.75K 10-Q · filed 2012-08-14 | $783.23K 10-Q · filed 2012-08-14 | $477.24K derived: sum of 3 quarters · filed 2012-08-14 | $557.93K derived: sum of 4 quarters · filed 2012-11-13 |
| 2012-03-31 | $218.70K 10-Q · filed 2012-05-14 | $4.50K derived: sum of 2 quarters · filed 2012-05-14 | $85.18K derived: sum of 3 quarters · filed 2012-11-13 | $145.78K derived: sum of 4 quarters · filed 2012-11-13 |
| 2011-12-31 | -$214.21K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | -$133.52K derived: sum of 2 quarters · filed 2012-11-13 | -$72.92K derived: sum of 3 quarters · filed 2012-11-13 | $0.00 10-K · filed 2012-03-29 |
| 2011-09-30 | $80.69K 10-Q · filed 2012-11-13 | $141.29K derived: sum of 2 quarters · filed 2012-11-13 | $214.21K 10-Q · filed 2012-11-13 | |
| 2011-06-30 | $60.60K 10-Q · filed 2012-08-14 | $133.52K 10-Q · filed 2012-08-14 | ||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-14 | |||
| 2010-12-31 | $287.45K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |